Drug intelligence / Profile preview

nitric oxide-releasing nanomatrix gel

Development stage
Preclinical
Lead developer
Endomimetics
Modality
Peptides
Administration
Implant, Subcutaneous, Topical
01

Overview

Nitric oxide-releasing nanomatrix gel (also known as Bionanomatrix gel or PANO gel) is a peptide amphiphile (PA)-based self-assembling nanomatrix gel designed to provide controlled, sustained release of nitric oxide (NO) directly to surgical sites. Developed by Endomimetics (a spinout from the University of Alabama at Birmingham), the gel mimics the natural endothelium to promote healthy healing, enhance vasodilation, and inhibit neointimal hyperplasia. Its lead application is for perivascular application during arteriovenous fistula (AVF) creation to prevent AVF maturation failure in hemodialysis patients. It is also being investigated for other applications, including subcutaneous injection for obesity and insulin resistance, and local application in orthopedic and dental procedures.

Brand names
Bionanomatrix
Other names
Bionanomatrix gelBionanomatrix Vascular Access Gel Formulationnitric oxide-releasing nanomatrix wrappeptide amphiphile nanomatrix gel
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on nitric oxide-releasing nanomatrix gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitric oxide-releasing nanomatrix gel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call